How have economic evaluations in relapsing multiple sclerosis evolved over time? A systematic literature review
A Wiyani, L Badgujar, V Khurana, N Adlard - Neurology and Therapy, 2021 - Springer
Introduction The introduction of disease-modifying therapies (DMTs) for relapsing multiple
sclerosis (RMS) over the last two decades has prompted the economic assessments of …
sclerosis (RMS) over the last two decades has prompted the economic assessments of …
[PDF][PDF] How have Economic Evaluations in Relapsing Multiple Sclerosis Evolved Over Time? A Systematic
A Wiyani, LBVKN Adlard - 2021 - academia.edu
Introduction: The introduction of diseasemodifying therapies (DMTs) for relapsing multiple
sclerosis (RMS) over the last two decades has prompted the economic assessments of …
sclerosis (RMS) over the last two decades has prompted the economic assessments of …